Exact Mass: 417.084848

Exact Mass Matches: 417.084848

Found 86 metabolites which its exact mass value is equals to given mass value 417.084848, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Grixazone B

Grixazone B

C18H15N3O7S (417.06306800000004)


A cysteine derivative that is the S-(2-amino-8-carboxy-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.

   

Pelargonidin 3-rhamnoside

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1λ⁴-chromen-1-ylium

C21H21O9+ (417.11855160000005)


Pelargonidin 3-rhamnoside is found in fruits. Pelargonidin 3-rhamnoside is isolated from Ficus sp. and others. Isolated from Ficus species and others. Pelargonidin 3-rhamnoside is found in herbs and spices and fruits.

   

Ochratoxin A methyl ester

5-Chloro-8-hydroxy-N-(1-methoxy-1-oxo-3-phenylpropan-2-yl)-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboximidate

C21H20ClNO6 (417.0979090000001)


   

Pexidartinib

5-({5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine

C20H15ClF3N5 (417.09680160000005)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Temafloxacin

1-(2,4-Difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(3-methyl-1-piperazinyl)quinoline-3-carboxylic acid, hydrochloride

C21H18F3N3O3 (417.13001940000004)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Triazolo-benzophenone

2-Amino-N-({4-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-methyl-4H-1,2,4-triazol-3-yl}methyl)ethanimidate

C19H17Cl2N5O2 (417.07592420000003)


   

Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(Cl)c1O

4-[2-(2-Amino-3-chloro-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulphonamide

C18H16ClN5O3S (417.06623360000003)


   

Gesnerin

5- (beta-D-Glucopyranosyloxy) -7-hydroxy-2- (4-hydroxyphenyl) -1-benzopyrylium

C21H21O9 (417.11855160000005)


   

Apigeninidin 7-glucoside

5,7,4-Trihydroxyflavylium 7-glucoside

C21H21O9 (417.11855160000005)


   
   

Pelargonidin 3-rhamnoside

3,5,7,4-Tetrahydroxyflavylium 3-rhamnoside

C21H21O9 (417.11855160000005)


   

3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE

3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE

C19H13F2N3O2S2 (417.04172220000004)


   
   
   

2-hydroxy-7-(beta-D-glucopyranosyloxymethyl)-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione

2-hydroxy-7-(beta-D-glucopyranosyloxymethyl)-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione

C17H23NO9S (417.1093468)


   
   
   

2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester

2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester

C21H20ClNO6 (417.0979090000001)


   

Coptisine sulfate

Coptisine (Sulfate)

C19H15NO8S (417.05183500000004)


Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1]. Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1].

   
   
   

Asn-TyrMe-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(4-methoxyphenyl)butanoic acid

C19H19N3O8 (417.1172094)


   

Tyr-Asn-OH

(S)-5-amino-2-(3-(4-hydroxyphenethoxy)-4-nitrobenzamido)-5-oxopentanoic acid

C19H19N3O8 (417.1172094)


   
   
   

dichlorodihydroxybis(isopropylamine)platinum

dichlorodihydroxybis(isopropylamine)platinum

C6H20Cl2N2O2Pt (417.05496100000005)


   

N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE

N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE

C20H17ClFN3O4 (417.08915640000004)


   

Bisoxatin acetate

[4-[2-(4-acetyloxyphenyl)-3-oxo-4H-1,4-benzoxazin-2-yl]phenyl] acetate

C24H19NO6 (417.12123140000006)


   

5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)

5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)

C19H15NO8S (417.05183500000004)


   

trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide

trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide

C16H24IN3O2 (417.0913194)


   
   
   

Bretazenil

Bretazenil

C19H20BrN3O3 (417.068795)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   
   

Sulfatolamide

4-(aminomethyl)benzenesulfonamide,(4-aminophenyl)sulfonylthiourea

C14H19N5O4S3 (417.0599134)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AE - Sulfonamides C254 - Anti-Infective Agent > C2166 - Combination Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

3,3-dimethyl-13-(4-nitrophenyl)-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione

3,3-dimethyl-13-(4-nitrophenyl)-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione

C23H19N3O5 (417.13246440000006)


   
   

4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]

4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]

C16H19NO10S (417.07296340000005)


   

Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized

Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized

C12H25MoN5O5------ (417.09096500000004)


   

3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile

3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile

C19H17Cl2N5S (417.0581662000001)


   

nile blue perchlorate

nile blue perchlorate

C20H20ClN3O5 (417.1091420000001)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile

3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile

C19H17Cl2N5S (417.0581662000001)


   

2-(5-Methoxy-1H-indol-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine

2-(5-Methoxy-1H-indol-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine

C23H19N3O3S (417.11470640000005)


   

5-O-(N-(Alanyl)sulfamoyl)adenosine

5-O-(N-(Alanyl)sulfamoyl)adenosine

C13H19N7O7S (417.1066624)


   

4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide

4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide

C18H16ClN5O3S (417.06623360000003)


   
   

N-(3-Chloro-4-Methoxy-Phenyl)-N-(3,4,5-Trimethoxyphenyl)-1,3,5-Triazine-2,4-Diamine

N-(3-Chloro-4-Methoxy-Phenyl)-N-(3,4,5-Trimethoxyphenyl)-1,3,5-Triazine-2,4-Diamine

C19H20ClN5O4 (417.1203750000001)


   

Pexidartinib

Pexidartinib

C20H15ClF3N5 (417.09680160000005)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

6-bromo-2-(4-methylphenyl)-N-(pyridin-3-yl)quinoline-4-carboxamide

6-bromo-2-(4-methylphenyl)-N-(pyridin-3-yl)quinoline-4-carboxamide

C22H16BrN3O (417.0476666)


   
   

6-[3-Hydroxy-2-(3,5,7-trioxononanoyl)phenyl]-3,5-dioxohexanoate

6-[3-Hydroxy-2-(3,5,7-trioxononanoyl)phenyl]-3,5-dioxohexanoate

C21H21O9- (417.11855160000005)


   
   

kaempferol 3-O-beta-D-xyloside(1-)

kaempferol 3-O-beta-D-xyloside(1-)

C20H17O10- (417.08216819999996)


An organic anion obtained by selective deprotonation of the 7-hydroxy group of kaempferol 3-O-beta-D-xyloside; major species at pH 7.3.

   

1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose

1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose

C12H19NO13S (417.0577084)


   

(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide

(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide

C19H15NO10 (417.06959300000005)


   

3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile

3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile

C23H15NO7 (417.084848)


   

N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide

N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide

C19H14F3N5OS (417.08711100000005)


   

1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine

1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine

C17H19N7O2S2 (417.10415939999996)


   

2-(2-furyl)-N-[(4-keto-3,5-dimethoxy-cyclohexa-2,5-dien-1-ylidene)methyl]cinchoninohydrazide

2-(2-furyl)-N-[(4-keto-3,5-dimethoxy-cyclohexa-2,5-dien-1-ylidene)methyl]cinchoninohydrazide

C23H19N3O5 (417.13246440000006)


   

Acetic acid [4-[acetyl-(4-chlorophenyl)sulfonylamino]-1-naphthalenyl] ester

Acetic acid [4-[acetyl-(4-chlorophenyl)sulfonylamino]-1-naphthalenyl] ester

C20H16ClNO5S (417.0437676000001)


   

N,N-diethyl-5-nitro-2-[(2-oxo-3-indolyl)hydrazo]benzenesulfonamide

N,N-diethyl-5-nitro-2-[(2-oxo-3-indolyl)hydrazo]benzenesulfonamide

C18H19N5O5S (417.1106844)


   

N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide

N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide

C19H19N3O4S2 (417.0816934)


   

3-(2-hydroxyphenyl)-N-{[5-(8-quinolinylthio)-2-furyl]methylene}propanohydrazide

3-(2-hydroxyphenyl)-N-{[5-(8-quinolinylthio)-2-furyl]methylene}propanohydrazide

C23H19N3O3S (417.11470640000005)


   

N-[(1S)-1-(1H-benzimidazol-2-yl)-3-(methylthio)propyl]-2-(4-chlorophenoxy)-2-methylpropanamide

N-[(1S)-1-(1H-benzimidazol-2-yl)-3-(methylthio)propyl]-2-(4-chlorophenoxy)-2-methylpropanamide

C21H24ClN3O2S (417.12776740000004)


   

(3E)-3-(4-bromobenzylidene)-1-(2-hydroxyphenyl)-5-phenyl-1,3-dihydro-2H-pyrrol-2-one

(3E)-3-(4-bromobenzylidene)-1-(2-hydroxyphenyl)-5-phenyl-1,3-dihydro-2H-pyrrol-2-one

C23H16BrNO2 (417.0364336)


   
   

2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide

2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide

C21H24ClN3O2S (417.12776740000004)


   

4-(4-Morpholinyl)-3-nitrobenzoic acid 2-[3-(cyanomethyl)-4-methyl-5-thiazol-3-iumyl]ethyl ester

4-(4-Morpholinyl)-3-nitrobenzoic acid 2-[3-(cyanomethyl)-4-methyl-5-thiazol-3-iumyl]ethyl ester

C19H21N4O5S+ (417.12325960000004)


   

N-[4-(4-chlorophenyl)-2-thiazolyl]-N-[3-(diethylamino)propyl]-2-furancarboxamide

N-[4-(4-chlorophenyl)-2-thiazolyl]-N-[3-(diethylamino)propyl]-2-furancarboxamide

C21H24ClN3O2S (417.12776740000004)


   

ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)

ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)

C6H20Cl2N2O2Pt (417.05496100000005)


   

Trovafloxacin(1+)

Trovafloxacin(1+)

C20H16F3N4O3+ (417.1174442)


An organic cation that is the conjugate acid of trovafloxacin, obtained by protonation of the primary amino group.

   

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

C16H24N3O8P-2 (417.1300954)


   

3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

C20H16FNO4S2 (417.0504748)


   

[3-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] 4-acetamidobenzenesulfonate

[3-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] 4-acetamidobenzenesulfonate

C18H15N3O5S2 (417.04531000000003)


   

temafloxacin

temafloxacin

C21H18F3N3O3 (417.13001940000004)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

C16H24N3O8P (417.1300954)


Dianion of N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.